You have 9 free searches left this month | for more free features.

Relapser

Showing 26 - 33 of 33

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Hepatitis C Trial run by the NIDDK (Peginterferon, Ribavirin)

Completed
  • Chronic Hepatitis C
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 10, 2014

Hepatitis C, Chronic Trial (PegIFN/RBV, BI 201335)

Withdrawn
  • Hepatitis C, Chronic
  • (no location specified)
Feb 23, 2013

Cardiovascular Diseases, Heart Diseases, Lung Diseases Trial (self-help, nicotine replacement therapy, smoking cessation)

Completed
  • Cardiovascular Diseases
  • +4 more
  • self-help
  • +2 more
  • (no location specified)
Mar 11, 2014

Hepatitis C Trial in United States (Infergen and ribavirin)

Terminated
  • Hepatitis C
  • Infergen and ribavirin
  • Atlanta, Georgia
  • +3 more
Oct 11, 2012

Hepatitis c Trial in San Antonio (pioglitazone (Actos), atorvastatin (Lipitor))

Completed
  • Hepatitis c
  • pioglitazone (Actos)
  • atorvastatin (Lipitor)
  • San Antonio, Texas
    Brooke Army Medical Center
Feb 13, 2012

Chronic Hepatitis C, Genotype 1, Relapse Trial in Omaha (Betaine, Peginterferon alpha 2a, Ribavirin)

Terminated
  • Chronic Hepatitis C
  • +2 more
  • Omaha, Nebraska
    University of Nebraska Medical Center
Aug 8, 2011

Liver Tissue and Blood From Individuals With Chronic Viral

Unknown status
  • Hepatitis C
  • +4 more
    • Toronto, Ontario, Canada
      Liver Clinic, Toronto Western Hospital, UHN
    Nov 29, 2005